Cholesterol

Cholesterol

SCHEMBL246637

CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C.O=C(O)Oc1ccccc1

nearest known ligand 0.79

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OSBP P22059 4/20 0.79
RORC P51449 3/20 0.79
OSBP2 Q969R2 2/20 0.79
CYP46A1 Q9Y6A2 2/20 0.79
USP2 O75604 1/20 0.79
LMNA P02545 1/20 0.79
ABCB1 P08183 1/20 0.79
NR1H3 Q13133 7/20 0.69
EPHA2 P29317 2/20 0.69
GRIN1 Q05586 2/20 0.68
GRIN2A Q12879 2/20 0.68
POLA1 P09884 1/20 0.67
NPC1L1 Q9UHC9 2/20 0.65
CRYAB P02511 1/20 0.65
HMGCR P04035 1/20 0.65
ITGB3 P05106 1/20 0.65
ITGAV P06756 1/20 0.65
SREBF2 Q12772 1/20 0.65
GRIN2B Q13224 1/20 0.64
DHCR24 Q15392 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cholesterol SCHEMBL21644732 0.96 OSBP (0.78) OSBPRORCOSBP2CYP46A1USP2
Cholesterol SCHEMBL21644734 0.96 OSBP (0.78) OSBPRORCOSBP2CYP46A1USP2
Cholesterol SCHEMBL246634 0.95 OSBP (0.79) OSBPRORCOSBP2CYP46A1USP2
Cholesterol SCHEMBL29194365 0.94 OSBP (0.77) OSBPRORCOSBP2CYP46A1USP2
Cholesterol SCHEMBL25352993 0.92 OSBP (0.72) OSBPRORCOSBP2CYP46A1USP2
Cholesterol SCHEMBL27608874 0.92 OSBP (0.91) OSBPRORCOSBP2CYP46A1USP2
Cholesterol SCHEMBL23069793 0.91 OSBP (0.86) OSBPRORCOSBP2CYP46A1USP2
Cholesterol SCHEMBL249324 0.91 OSBP (0.86) OSBPRORCOSBP2CYP46A1USP2
Cholesterol SCHEMBL29502101 0.91 OSBP (0.93) OSBPRORCOSBP2CYP46A1USP2
Cholesterol SCHEMBL1369602 0.91 OSBP (0.93) OSBPRORCOSBP2CYP46A1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060115445-A1 Compositions for treating keratin materials comprising electrophilic monomers and liquid crystal agents L'OREAL S.A. (FR) 2006-06-01 US claimed
EP-1647259-A1 use for treatment of keratinic materials of compositions comprising electrophilic monomers and agents forming liquid crystals L'OREAL (FR) 2006-04-19 EP claimed
US-6328910-B1 FOR IN SITU FORMATION OF AN POLYMERIC CYANOACRYLATE FILM ON MAMMALIAN SKIN WHICH CAN BE USED TO MONITOR THE SURFACE SKIN TEMPERATURE OF MAMMAL MEDLOGIC GLOBAL CORPORATION 2001-12-11 US claimed
CN-105596233-B Anhydrous fluid filter composition comprising an oily phase, a specific triazine filter and a rheological agent for thickening or gelling the oil 莱雅公司 2020-11-06 CN disclosed
EP-2345456-B1 ANHYDROUS LIQUID SCREENING COMPOSITION CONTAINING AN OILY PHASE, A SPECIFIC TRIAZINE FILTER AND AN OILY REOLOGICAL THICKENING OR GELIFYING AGENT. L'ORÉAL (FR) 2017-05-03 EP disclosed
US-20120100089-A1 COSMETIC COMPOSITION FOR MAKEUP AND/OR KERATIN MATERIAL CARE, BASED ON A MIXTURE OF RESINS MQ AND T-PR, AND MAKEUP METHOD L'OREAL (FR) 2012-04-26 US disclosed
US-20120064019-A1 COSMETIC COMPOSITION FOR MAKING-UP AND/OR CARING FOR KERATIN MATERIALS AND MAKE-UP METHOD L'OREAL (FR) 2012-03-15 US disclosed
US-20120003167-A1 COSMETIC COMPOSITION COMPRISING SILOXANE RESINS AND AT LEAST ONE PHENYL SILICONE OIL L'OREAL (FR) 2012-01-05 US disclosed
EP-2373279-A2 COSMETIC COMPOSITION COMPRISING SILOXANE RESINS AND AT LEAST ONE PHENYLATED SILICONE OIL L'Oréal (FR) 2011-10-12 EP disclosed
EP-2373284-A2 COSMETIC COMPOSITION FOR MAKEUP AND/OR KERATIN MATERIAL CARE, BASED ON A MIXTURE OF RESINS MQ AND T-PR, AND MAKEUP METHOD L'Oréal (FR) 2011-10-12 EP disclosed
EP-2373285-A2 COSMETIC COMPOSITION FOR MAKING-UP AND/OR CARING FOR KERATIN MATERIALS AND MAKE-UP METHOD L'Oréal (FR) 2011-10-12 EP disclosed
WO-2010063959-A2 COSMETIC COMPOSITION FOR MAKING-UP AND/OR CARING FOR KERATIN MATERIALS AND MAKE-UP METHOD L'OREAL (FR) 2010-06-10 WO disclosed
WO-2010063964-A2 COSMETIC COMPOSITION FOR MAKING-UP AND/OR CARING FOR KERATIN MATERIALS AND MAKE-UP METHOD L'OREAL (FR) 2010-06-10 WO disclosed
WO-2010063965-A2 COSMETIC COMPOSITION FOR MAKING-UP AND/OR CARING FOR KERATIN MATERIAL AND MAKE-UP METHOD L'OREAL (FR) 2010-06-10 WO disclosed
WO-2010063967-A2 COSMETIC COMPOSITION FOR MAKING-UP AND/OR CARING FOR KERATIN MATERIAL AND MAKE-UP METHOD L'OREAL (FR) 2010-06-10 WO disclosed
WO-2010063963-A2 COSMETIC COMPOSITION FOR MAKING-UP AND/OR CARING FOR KERATIN MATERIALS AND MAKE-UP METHOD L'OREAL (FR) 2010-06-10 WO disclosed
EP-2135525-A2 Eyelash make-up and/or care kit L'Oréal (FR) 2009-12-23 EP disclosed
US-20060115445-A1 Compositions for treating keratin materials comprising electrophilic monomers and liquid crystal agents L'OREAL S.A. (FR) 2006-06-01 US disclosed
EP-1647259-A1 use for treatment of keratinic materials of compositions comprising electrophilic monomers and agents forming liquid crystals L'OREAL (FR) 2006-04-19 EP disclosed
US-6328910-B1 FOR IN SITU FORMATION OF AN POLYMERIC CYANOACRYLATE FILM ON MAMMALIAN SKIN WHICH CAN BE USED TO MONITOR THE SURFACE SKIN TEMPERATURE OF MAMMAL MEDLOGIC GLOBAL CORPORATION 2001-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120003167-A1 COSMETIC COMPOSITION COMPRISING SILOXANE RESINS AND AT LEAST ONE PHENYL SILICONE OIL QSOX1, RXRB, PRXL2A OSBP 2210/4885RORC 3184/4885OSBP2 2340/4885
US-20060115445-A1 Compositions for treating keratin materials comprising electrophilic monomers and liquid crystal agents KRT18, PRKDC, CUTA OSBP 2396/4885RORC 3212/4885OSBP2 2545/4885
US-20120064019-A1 COSMETIC COMPOSITION FOR MAKING-UP AND/OR CARING FOR KERATIN MATERIALS AND MAKE-UP METHOD PLOD3, ALOX15, ELOVL1 OSBP 663/4885RORC 2929/4885OSBP2 1954/4885
US-20120100089-A1 COSMETIC COMPOSITION FOR MAKEUP AND/OR KERATIN MATERIAL CARE, BASED ON A MIXTURE OF RESINS MQ AND T-PR, AND MAKEUP METHOD KRT18, TERB1, VIM OSBP 2405/4885RORC 1920/4885OSBP2 3383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.